酪氨酸蛋白激酶B3抗體
	規(guī)格:1mg/1ml 
	
		英文名: Ephrin B3
	
	
		別名: Ephrin B3; EphrinB3 antibody EPH related receptor transmembrane ligand ELK L3; EPH related receptor tyrosine kinase ligand 8; Ephrin B3; EphrinB3; EPLG 8; LERK 8; EFL 6; EFL6; EFNB 3; EFNB3; EFNB3_HUM
	
	
		分子量: 34kDa
	
	
		儲存液:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glyce
	
	
		克隆類型:Polyclonal
	
	
		亞型:IgG
	
	
		純化方法:affinity purified by Protein A
	
	
		**原:KLH conjugated synthetic peptide derived from human Ephrin B
	
	
		交叉反應(yīng):Human, Mouse, Rat, Pig, Cow, Horse, Rabbit,
	
	
		細(xì)胞定位:細(xì)胞膜
	
	
		酪氨酸蛋白激酶B3抗體產(chǎn)品介紹:background: May play a pivotal role in forebrain function. Binds to, and induce the collapse of, commissural axons/growth cones in vitro. May play a role in constraining the orientation of longitudinally projecting axons. Tissue specificity: Highly expressed in brain; expressed in embryonic floor plate, roof plate and hindbrain segments. Subunit: Interacts with GRIP1 and GRIP2. Binds to Nipah virus G protein. Subcellular Location: Membrane; Single-pass type I membrane protein. Tissue Specificity: Highly酪氨酸蛋白激酶B3抗體 expressed in brain; expressed in embryonic floor plate, roof plate and hindbrain segments.酪氨酸蛋白激酶B3抗體 Similarity: Belongs to the ephrin family. Contains 1 ephrin RBD (ephrin receptor-binding) domain. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
	
	
		酪氨酸蛋白激酶B3抗體產(chǎn)品應(yīng)用:WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
	
	
		研究領(lǐng)域:心血管  細(xì)胞生物  神經(jīng)生物學(xué)  信號轉(zhuǎn)導(dǎo)  激酶和磷酸酶  
	
	
		儲存條件:	Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
	
	
		來源:	Rabbit
	
	
		外觀:	Lyophilized or Liquid
	
	
	
	
   
    
        - 溫馨提示:為規(guī)避購買風(fēng)險(xiǎn),建議您在購買前務(wù)必確認(rèn)供應(yīng)商資質(zhì)與產(chǎn)品質(zhì)量。
 
        - 免責(zé)申明:以上內(nèi)容為注冊會員自行發(fā)布,若信息的真實(shí)性、合法性存在爭議,平臺將會監(jiān)督協(xié)助處理,歡迎舉報(bào)